Drugs.com - Pharma Industry News

HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia

THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ejaculatory function...

Feb 9, 2025 - 21:45
 0
HoLEP Double-n Technology Promising for Benign Prostatic Hyperplasia
THURSDAY, Feb. 6, 2025 -- For men with benign prostatic hyperplasia (BPH), transurethral Holmium Laser of the Prostate (HoLEP) with Double-n Technology shows promise for improving urinary symptoms while better preserving ejaculatory function...
Read More

Tags:

Previous Article

Nivolumab Added to Chemo Improves Response in ER+, HER2− Breast Cancer

Next Article

Three All-Oral Shortened Regimens Noninferior for Rifampin-Resistant TB

Related Posts

Maternal Health in Pregnancy Tied to Risk for Autism in Offspring

Maternal Health in Pregnancy Tied to Risk for Autism in...

Feb 20, 2025  0

Chronic Conditions and Their Age of Onset Predict Health Trajectory in IBD

Chronic Conditions and Their Age of Onset Predict Healt...

Mar 24, 2025  0

Minimal TV Viewing May Cut ASCVD Risk in Those With T2DM Genetic Risk

Minimal TV Viewing May Cut ASCVD Risk in Those With T2D...

Mar 12, 2025  0